Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
AMC, Teva, launch coalition for equity through digital health
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
Teva Pharmaceuticals - Wikipedia
Jury holds drugmaker Teva liable in opioid crisis | WLUK
Global Biosimilar Hormones Market 2021, Industry Trends,
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva, lured by $40M tax break, packs its bags for New Jersey HQ move | Fierce Pharma
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia | Business Wire
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
News & Media
The ALS Association, Huntington's Disease Society of America, and Teva Pharmaceuticals Launch Teva CNS Target Identification Challenge | The ALS Association
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva shed 37% of Israel workforce in two years - Globes
New branded drugs helping Teva Pharm move closer to growth | Reuters
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals | Business Wire
